Outcome Of Omalizumab (anti-Ige) Therapy For Severe Persistent Asthma In Inner City Children And Adolescents

被引：0
|
作者：
Ahmad, S. [1 ]
Agrawal, S. [1 ]
Solomon, G. [1 ]
Lee, H. [1 ]
机构：
[1] Suny Downstate Med Ctr, Dept Pediat, Div Pediat Pulmonol, Brooklyn, NY 11203 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4242
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
    Busse, William W.
    Morgan, Wayne J.
    Gergen, Peter J.
    Mitchell, Herman E.
    Gern, James E.
    Liu, Andrew H.
    Gruchalla, Rebecca S.
    Kattan, Meyer
    Teach, Stephen J.
    Pongracic, Jacqueline A.
    Chmiel, James F.
    Steinbach, Suzanne F.
    Calatroni, Agustin
    Togias, Alkis
    Thompson, Katherine M.
    Szefler, Stanley J.
    Sorkness, Christine A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1005 - 1015
  • [2] Anti-IgE for Asthma in Inner-City Children
    Geraci, Cecilia
    Longo, Giorgio
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2557 - 2557
  • [3] Persistent severe egg allergy successfully responds to anti-IgE therapy (omalizumab)
    Huertas, B.
    Hinojosa, M.
    De la Hoz, B.
    Berges, P.
    Terrados, S.
    Pena, M.
    Alvarez-Cuesta, E.
    ALLERGY, 2010, 65 : 385 - 385
  • [4] Anti-IgE in severe persistent allergic asthma
    Fox, Howard
    RESPIROLOGY, 2007, 12 : S22 - S28
  • [5] Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
    Pelaia, Girolamo
    Vatrella, Alessandro
    Busceti, Maria Teresa
    Gallelli, Luca
    Terracciano, Rosa
    Maselli, Rosario
    CURRENT DRUG TARGETS, 2015, 16 (02) : 171 - 178
  • [6] Obesity influences the outcomes of anti-IgE (omalizumab) therapy of asthma
    Gu, Chao
    Upchurch, Katherine
    Mamaril-Davis, James
    Wiest, Matthew
    Lanier, Bobby
    Millard, Mark
    Turner, Jacob
    Joo, HyeMee
    Oh, SangKon
    CLINICAL AND EXPERIMENTAL ALLERGY, 2020, 50 (10): : 1196 - 1199
  • [7] Anti-IgE therapy for children and adolescents
    Wahn, U.
    Hamelmann, E.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (02) : 134 - 137
  • [8] Greater Treatment Benefit with Omalizumab in Children with Increased Asthma Severity: Exploratory Analyses from the Inner-City Anti-IgE Therapy for Asthma (ICATA) Study
    Busse, William W.
    Haselkorn, Tmirah
    Rosen, Karin
    Trzaskoma, Benjamin L.
    Ortiz, Benjamin
    Szefler, Stanley J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB14 - AB14
  • [9] Omalizumab (Xolair®) first anti-IgE antibody for treatment of poorly controlled severe persistent allergic asthma
    Pierre, Jacques
    PRESSE MEDICALE, 2007, 36 (03): : 444 - 444
  • [10] Omalizumab: Anti-IgE Therapy in Allergy
    Matthias Volkmar Kopp
    Current Allergy and Asthma Reports, 2011, 11 : 101 - 106
12345